(MT Newswires) -- AstraZeneca (AZN) Chief Executive Officer Pascal Soriot discusses the drugmaker's business strategy in China, the US "BIOSECURE Act," and future deals and partnerships in China. He speaks with Stephen Engle on the sidelines of the BOAO forum.

Bloomberg videos